Synergistical Use of Electrostatic and Hydrophobic Interactions for the Synthesis of a New Class of Multifunctional Nanohybrids: Plasmonic Magneto-Liposomes

Overview

Journal Nanomaterials (Basel)

Date 2019 Nov 17

PMID 31731719

Citations 5

Authors

Gabriela Fabiola Stiufiuc

Stefan Nitica

Valentin Toma

Cristian Iacovita

Dietrich Zahn

Romulus Tetean

Emil Burzo

Constantin Mihai Lucaciu

Rares Ionut Stiufiuc

Affiliations

Soon will be listed here.

Abstract

By carefully controlling the electrostatic interactions between cationic liposomes, which already incorporate magnetic nanoparticles in the bilayers, and anionic gold nanoparticles, a new class of versatile multifunctional nanohybrids (plasmonic magneto-liposomes) that could have a major impact in drug delivery and controlled release applications has been synthesized. The experimental results confirmed the successful synthesis of hydrophobic superparamagnetic iron oxide nanoparticles (SPIONs) and polyethylene glycol functionalized (PEGylated) gold nanoparticles (AuNPs). The SPIONs were incorporated in the liposomal lipidic bilayers, thus promoting the formation of cationic magnetoliposomes. Different concentrations of SPIONs were loaded in the membrane. The cationic magnetoliposomes were decorated with anionic PEGylated gold nanoparticles using electrostatic interactions. The successful incorporation of SPIONs together with the modifications they generate in the bilayer were analyzed using Raman spectroscopy. The plasmonic properties of the multifunctional nanohybrids were investigated using UV-Vis absorption and (surface-enhanced) Raman spectroscopy. Their hyperthermic properties were recorded at different frequencies and magnetic field intensities. After the synthesis, the nanosystems were extensively characterized in order to properly evaluate their potential use in drug delivery applications and controlled release as a result of the interaction with an external stimulus, such as an NIR laser or alternating magnetic field.

Citing Articles

Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment.

Nitica S, Fizesan I, Dudric R, Loghin F, Lucaciu C, Iacovita C Pharmaceutics. 2022; 14(11).

PMID: 36432692 PMC: 9697793. DOI: 10.3390/pharmaceutics14112501.

Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes-A Preliminary Study.

Bartos A, Iancu I, Ciobanu L, Onaciu A, Moldovan C, Moldovan A Nanomaterials (Basel). 2022; 12(16).

PMID: 36014698 PMC: 9414144. DOI: 10.3390/nano12162833.

Quantifying Cytosolic Cytochrome c Concentration Using Carbon Quantum Dots as a Powerful Method for Apoptosis Detection.

Moldovan C, Onaciu A, Toma V, Marginean R, Moldovan A, Tigu A Pharmaceutics. 2021; 13(10).

PMID: 34683849 PMC: 8537359. DOI: 10.3390/pharmaceutics13101556.

A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.

Barbalata C, Porfire A, Sesarman A, Rauca V, Banciu M, Muntean D Pharmaceutics. 2021; 13(10).

PMID: 34683821 PMC: 8537800. DOI: 10.3390/pharmaceutics13101526.

Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma.

Stiufiuc G, Toma V, Buse M, Marginean R, Morar-Bolba G, Culic B Nanomaterials (Basel). 2020; 10(6).

PMID: 32575924 PMC: 7353077. DOI: 10.3390/nano10061212.

References

Sahoo S, Parveen S, Panda J . The present and future of nanotechnology in human health care. Nanomedicine. 2007; 3(1):20-31. DOI: 10.1016/j.nano.2006.11.008. View

Iacovita C, Stiufiuc R, Radu T, Florea A, Stiufiuc G, Dutu A . Polyethylene Glycol-Mediated Synthesis of Cubic Iron Oxide Nanoparticles with High Heating Power. Nanoscale Res Lett. 2015; 10(1):391. PMC: 4596149. DOI: 10.1186/s11671-015-1091-0. View

Balazs D, Godbey W . Liposomes for use in gene delivery. J Drug Deliv. 2011; 2011:326497. PMC: 3066571. DOI: 10.1155/2011/326497. View

Stiufiuc R, Iacovita C, Stiufiuc G, Florea A, Achim M, Lucaciu C . A new class of pegylated plasmonic liposomes: synthesis and characterization. J Colloid Interface Sci. 2014; 437:17-23. DOI: 10.1016/j.jcis.2014.09.023. View

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

Chang H, Yeh M . Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine. 2012; 7:49-60. PMC: 3260950. DOI: 10.2147/IJN.S26766. View

Hervault A, Thanh N . Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 2014; 6(20):11553-73. DOI: 10.1039/c4nr03482a. View

Sercombe L, Veerati T, Moheimani F, Wu S, Sood A, Hua S . Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol. 2015; 6:286. PMC: 4664963. DOI: 10.3389/fphar.2015.00286. View

Chourpa I, Douziech-Eyrolles L, Ngaboni-Okassa L, Fouquenet J, Cohen-Jonathan S, Souce M . Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst. 2005; 130(10):1395-403. DOI: 10.1039/b419004a. View

10.

Yang F, Jin C, Jiang Y, Li J, Di Y, Ni Q . Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treat Rev. 2011; 37(8):633-42. DOI: 10.1016/j.ctrv.2011.01.006. View

11.

Zeng S, Baillargeat D, Ho H, Yong K . Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications. Chem Soc Rev. 2014; 43(10):3426-52. DOI: 10.1039/c3cs60479a. View

12.

Kim S, Saha K, Kim C, Rotello V . The role of surface functionality in determining nanoparticle cytotoxicity. Acc Chem Res. 2013; 46(3):681-91. PMC: 3640732. DOI: 10.1021/ar3000647. View

13.

Zylberberg C, Matosevic S . Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv. 2016; 23(9):3319-3329. DOI: 10.1080/10717544.2016.1177136. View

14.

Yeh Y, Creran B, Rotello V . Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale. 2011; 4(6):1871-80. PMC: 4101904. DOI: 10.1039/c1nr11188d. View

15.

Khlebtsov N, Bogatyrev V, Dykman L, Khlebtsov B, Staroverov S, Shirokov A . Analytical and theranostic applications of gold nanoparticles and multifunctional nanocomposites. Theranostics. 2013; 3(3):167-80. PMC: 3590586. DOI: 10.7150/thno.5716. View

16.

Lee J, Kim J, Cheon J . Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells. 2013; 35(4):274-84. PMC: 3887886. DOI: 10.1007/s10059-013-0103-0. View

17.

Gonzales-Weimuller M, Zeisberger M, Krishnan K . Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J Magn Magn Mater. 2015; 321(13):1947-1950. PMC: 4578659. DOI: 10.1016/j.jmmm.2008.12.017. View

18.

Daniel M, Astruc D . Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004; 104(1):293-346. DOI: 10.1021/cr030698+. View

19.

Duncan B, Kim C, Rotello V . Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release. 2010; 148(1):122-127. PMC: 2952284. DOI: 10.1016/j.jconrel.2010.06.004. View

20.

Etheridge M, Campbell S, Erdman A, Haynes C, Wolf S, McCullough J . The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2012; 9(1):1-14. PMC: 4467093. DOI: 10.1016/j.nano.2012.05.013. View